Rang	Name	Position
1	Dr. Albert Bourla D.V.M., Ph.D.	Chairman of the Board & CEO
2	Dr. Chris Boshoff FMedSci, M.D., Ph.D.	Chief Scientific Officer and President of Research & Development
3	Mr. Douglas M. Lankler	Executive VP & Chief Legal Officer
4	Mr. Aamir Malik	Executive VP & Chief U.S. Commercial Officer
5	Ms. Cecile Guegan	Interim CFO & Executive VP
6	Ms. Jennifer B. Damico	Senior VP, Controller & Principal Accounting Officer
7	Mr. Dennis P. Hancock	Executive VP & Chief Information Officer
8	Ms. Francesca M. DeMartino	Chief Investor Relations Officer
9	Ms. Payal Sahni Becher	Chief People Experience Officer & Executive VP
10	Dr. Michael S. Vincent M.D., Ph.D.	Senior VP and Chief Scientific Officer of Inflammation & Immunology

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	BlackRock Inc	8,74%	13,81 Mrd. USD
2	Vanguard Capital Management, LLC	6,48%	10,24 Mrd. USD
3	State Street Corp	5,29%	8,36 Mrd. USD
4	Geode Capital Management, LLC	2,34%	3,70 Mrd. USD
5	Vanguard Portfolio Management, LLC	2,05%	3,24 Mrd. USD
6	Fisher Asset Management, LLC	1,91%	3,02 Mrd. USD
7	Morgan Stanley - Brokerage Accounts	1,63%	2,57 Mrd. USD
8	Northern Trust Corp	1,09%	1,72 Mrd. USD
9	NORGES BANK	1,08%	1,71 Mrd. USD
10	Massachusetts Financial Services Company	1,00%	1,58 Mrd. USD
11	State Farm Mutual Automobile Ins Co	0,96%	1,51 Mrd. USD
12	Bank of New York Mellon Corp	0,95%	1,49 Mrd. USD
13	Charles Schwab Investment Management Inc	0,91%	1,44 Mrd. USD
14	The Goldman Sachs Group Inc	0,83%	1,31 Mrd. USD
15	Bank of America Corp	0,82%	1,29 Mrd. USD
16	Legal & General Group PLC	0,76%	1,21 Mrd. USD
17	Amundi	0,72%	1,13 Mrd. USD
18	Dimensional Fund Advisors, Inc.	0,67%	1,06 Mrd. USD
19	UBS Asset Mgmt Americas Inc	0,61%	0,96 Mrd. USD
20	Royal Bank of Canada	0,60%	0,95 Mrd. USD